138 related articles for article (PubMed ID: 6884417)
1. Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination.
Roux A; Le Liboux A; Delhotal B; Gaillot J; Flouvat B
Eur J Clin Pharmacol; 1983; 24(6):801-6. PubMed ID: 6884417
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).
Gulaid AA; James IM; Kaye CM; Lewellen OR; Roberts E; Sankey M; Smith J; Templeton R; Thomas RJ
Biopharm Drug Dispos; 1981; 2(2):103-14. PubMed ID: 7248475
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects.
Roux A; Henry JF; Fouache Y; Chau NP; Hervy MP; Forette F; Bourdarias JP; Flouvat B
Gerontology; 1983; 29(3):202-8. PubMed ID: 6852547
[TBL] [Abstract][Full Text] [Related]
5. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
Kirch W; Köhler H; Berggren G; Braun W
Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
[TBL] [Abstract][Full Text] [Related]
6. Acebutolol pharmacokinetics in renal failure.
Smith RS; Warren DJ; Renwick AG; George CF
Br J Clin Pharmacol; 1983 Sep; 16(3):253-8. PubMed ID: 6626416
[TBL] [Abstract][Full Text] [Related]
7. Observations on the pharmacokinetics of acebutolol.
Kaye CM; Kumana CR; Leighton M; Hamer J; Turner P
Clin Pharmacol Ther; 1976 Apr; 19(4):416-20. PubMed ID: 1269192
[TBL] [Abstract][Full Text] [Related]
8. Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.
Sankey MG; Gulaid A; Kaye CM
J Pharm Pharmacol; 1984 Apr; 36(4):276-7. PubMed ID: 6144783
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the efficacy and acceptability of an acebutolol/hydrochlorothiazide combination in the treatment of mild to moderate essential hypertension.
Nievel JG; Harvard CW
Curr Med Res Opin; 1981; 7(8):526-35. PubMed ID: 7030637
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.
Zaman R; Jack DB; Wilkins MR; Kendall MJ
Biopharm Drug Dispos; 1985; 6(2):131-7. PubMed ID: 4005393
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of hydrochlorothiazide in relation to renal function.
Niemeyer C; Hasenfuss G; Wais U; Knauf H; Schäfer-Korting M; Mutschler E
Eur J Clin Pharmacol; 1983; 24(5):661-5. PubMed ID: 6873147
[TBL] [Abstract][Full Text] [Related]
12. Effects of grapefruit juice on the pharmacokinetics of acebutolol.
Lilja JJ; Raaska K; Neuvonen PJ
Br J Clin Pharmacol; 2005 Dec; 60(6):659-63. PubMed ID: 16305592
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of acebutolol].
Collins RF
Nouv Presse Med; 1975 Dec; 4(46 Suppl):3223-8. PubMed ID: 768905
[TBL] [Abstract][Full Text] [Related]
14. Acebutolol disposition after intravenous administration.
Meffin PJ; Winkle RA; Peters FA; Harrison DC
Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):557-67. PubMed ID: 913023
[TBL] [Abstract][Full Text] [Related]
15. Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.
Munn S; Bailey RR; Begg E; Ebert R; Ferry DG
N Z Med J; 1980 Apr; 91(658):289-91. PubMed ID: 6930006
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide.
Jordö L; Johnsson G; Lundborg P; Persson BA; Regärdh CG; Rönn O
Br J Clin Pharmacol; 1979 Jun; 7(6):563-7. PubMed ID: 465277
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic comparison of a combination tablet of enalapril and hydrochlorothiazide with enalapril and hydrochlorothiazide tablets administered together and separately.
Howes LG; Conway EL; Phillips PA; Broadbear J; Drummer OH; Louis WJ
Biopharm Drug Dispos; 1991; 12(6):447-55. PubMed ID: 1932608
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of acebutolol enantiomers in humans.
Piquette-Miller M; Foster RT; Kappagoda CT; Jamali F
J Pharm Sci; 1991 Apr; 80(4):313-6. PubMed ID: 1865329
[TBL] [Abstract][Full Text] [Related]
19. A comparative pharmacokinetic and pharmacodynamic study of conventional and sustained-release preparations of acebutolol in healthy volunteers.
Fleurot O; Lecocq B; Lecocq V; Le Liboux A; Montay G; Frydman A; Jaillon P
Fundam Clin Pharmacol; 1991; 5(7):601-9. PubMed ID: 1778538
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of moderate hypertension with the calcium antagonist nitrendipine in combination with beta receptor blocker or diuretic].
Overlack A; Müller HM; Kolloch R; Stumpe KO
Med Klin (Munich); 1990 Aug; 85(8):467-71. PubMed ID: 2233598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
